Michael Andrew Chambers insider trades

Open-market stock purchases and sales by Michael Andrew Chambers, Unknown at Sarepta Therapeutics, Inc, from SEC Form 4 filings since Jun 2, 2022.

Track record: 0% of 14 scored buys are up 5% or more since purchase, averaging -86%.

Recent trades

DateStockTradeValue
Jun 4, 2026SRPT Sarepta Therapeutics, IncBought (not open market)—
Dec 18, 2025SRPT Sarepta Therapeutics, IncBought (not open market)$20M
Dec 18, 2025SRPT Sarepta Therapeutics, IncSold (not open market)$20M

Companies traded

  • SRPT Sarepta Therapeutics, Inc: 14 buys, last Jun 4, 2026

Get free alerts when Michael Andrew Chambers files a new trade →